Article Information
History
- April 1, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Kevin Oware1,*,
- Lydia Adiema1,
- Bernard Rono1,
- Lauren R. Violette3,4,
- R. Scott McClelland2,3,4,
- Deborah Donnell6,
- Caitlin W. Scoville2,
- Josephine Odoyo1,
- Jared M. Baeten2,3,4,7,
- Elizabeth Bukusi1,2,5 and
- Jenell Stewart2,3
- 1Kenya Medical Research Institute (KEMRI), Kisumu, Kenya
- 2Departments of Global Health, University of Washington, Seattle, United States
- 3Medicine (Infectious Diseases), University of Washington, Seattle, United States
- 4Epidemiology, University of Washington, Seattle, United States
- 5Obstetrics and Gynaecology, University of Washington, Seattle, United States
- 6Fred Hutchinson Cancer Research Center, Seattle, United States
- 7Gilead Sciences, Foster City, United States
- ↵*Corresponding Author contact information: Kevin Oware, MA, Kenya Medical Research Institute, Kisumu, Kenya, kkamolloh{at}kemri-ucsf.org / kamolloh2005{at}gmail.com
Posted April 01, 2022.
Characteristics of Kenyan Women Enrolled in a Trial on Doxycycline Postexposure Prophylaxis for Sexually Transmitted Infection Prevention
